After seven years in the pharmacy world, Helen Gordon is departing as chief executive of the Royal Pharmaceutical Society to enter pastures new at the Royal Society of Medicine. Here, she talks to Julia Robinson about her proudest moments and what advice she would give to her successor.
The 2017 Royal Pharmaceutical Society (RPS) budget, agreed in November 2016, includes a financial surplus of £5,000 before interest. Here Simon Redman, director of finance at the RPS, talks to Julia Robinson about how the RPS has recovered from last year’s budgeted loss of £1.5m and what plans are being made to improve services and engage with members in the coming year.
Six candidates in the race to be director-general of the World Health Organization outline their priorities and vision for global health.
Maree Todd, pharmacist and member of the Scottish Parliament, speaks to Jenny Bryan about the successes of community pharmacy in Scotland, what can England learn from them and her life in politics so far.
In light of the government’s intention to cut funding for the sector and reform the remuneration structure, we asked four people from four different community pharmacy backgrounds to share their views.
Q&A: World Bank warns that inaction on antimicrobial resistance could increase healthcare costs in developing countriesSubscription
Tim Evans from the World Bank Group talks about new research that shows how inaction on antimicrobial resistance could wipe out decades of healthcare gains and dramatically increase healthcare costs in developing countries.
What is the Falsified Medicines Directive? Subscription
Aileen Bryson, practice and policy lead at RPS Scotland, speaks to Julia Robinson about the purpose of the Falsified Medicines Directive and how it will affect pharmacists in the UK.
Q&A: From training surgeons in Ireland to providing healthcare education internationallySubscription
Paul Gallagher, head of the school of pharmacy at the Royal College of Surgeons in Ireland, speaks to Benedict Lam about how the royal college focus on education and training led to the expansion of its provision of healthcare education in Ireland and beyond.
In 2015, the Royal Pharmaceutical Society signed an agreement with the Japanese Pharmaceutical Association promising to work together and share best practice on patient care and professional development. Here, Julia Robinson talks to Naoko Arakawa, the international programme lead at the RPS, about the collaboration so far.
Nicola Magrini from the World Health Organization discusses improving access to affordable medicines for non-communicable diseases and warns that treatments for cancer lag behind.